108422002: Dolasetron mesilate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\5-HT3 receptor antagonist\Dolasetron mesilate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\5-HT3 receptor antagonist\Dolasetron mesilate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

172956017 Dolasetron mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3726181015 Dolasetron mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

18141000188113 dolasétron mésilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dolasetron mesilate	Is a	Product containing dolasetron (medicinal product)	false	Inferred relationship	Some
Dolasetron mesilate	Is a	Dolasetron (substance)	false	Inferred relationship	Some
Dolasetron mesilate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	5-HT3 receptor antagonist	true	Inferred relationship	Some
Dolasetron mesilate	Is a	5-HT3 receptor antagonist	true	Inferred relationship	Some
Dolasetron mesilate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Dolasetron (substance)	true	Inferred relationship	Some
Dolasetron mesilate	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Dolasetron mesilate 20mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Dolasetron mesilate 20 mg powder for solution for injection ampoule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Dolasetron mesilate 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Dolasetron mesilate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some	1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolasetron mesilate	Inferred relationship	Some	1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 20 mg powder for solution for injection ampoule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Dolasetron mesilate	Inferred relationship	Some	1
Dolasetron mesilate 20 mg powder for solution for injection ampoule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Dolasetron mesilate	Inferred relationship	Some	1

Reference Sets